Inactive Instrument

Sector Chart Tekmira Pharmaceuticals Corporation Toronto S.E.

Equities

TKM

CA87911B2093

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
92.38B
37.9B
33.73B
27.98B
15.86B